A. G. Komarova, N. L. Lyakhova, S. D. Covantsev, E. A. Naryshkina, D. V. Slepukhova
{"title":"房颤和慢性肾病患者的抗凝治疗:支持或反对的争论","authors":"A. G. Komarova, N. L. Lyakhova, S. D. Covantsev, E. A. Naryshkina, D. V. Slepukhova","doi":"10.33667/2078-5631-2023-25-14-20","DOIUrl":null,"url":null,"abstract":"Atrial fibrillation and chronic renal failure are common diseases in the population with similar risk factors. Both conditions are independent riskfactors for the development of thromboembolic complications. There is compelling evidence to support the benefits of anticoagulant therapy for atrial fibrillation in the general population, but in patients with advanced chronic renal failure, the use of anticoagulants may be limited. A number of studies have shown conflicting results, and this topic is of interest for further discussion and a comprehensive analysis of the existing data.","PeriodicalId":499576,"journal":{"name":"Medicinskij alfavit","volume":"58 12","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: Arguments for or against\",\"authors\":\"A. G. Komarova, N. L. Lyakhova, S. D. Covantsev, E. A. Naryshkina, D. V. Slepukhova\",\"doi\":\"10.33667/2078-5631-2023-25-14-20\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Atrial fibrillation and chronic renal failure are common diseases in the population with similar risk factors. Both conditions are independent riskfactors for the development of thromboembolic complications. There is compelling evidence to support the benefits of anticoagulant therapy for atrial fibrillation in the general population, but in patients with advanced chronic renal failure, the use of anticoagulants may be limited. A number of studies have shown conflicting results, and this topic is of interest for further discussion and a comprehensive analysis of the existing data.\",\"PeriodicalId\":499576,\"journal\":{\"name\":\"Medicinskij alfavit\",\"volume\":\"58 12\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicinskij alfavit\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33667/2078-5631-2023-25-14-20\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicinskij alfavit","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33667/2078-5631-2023-25-14-20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: Arguments for or against
Atrial fibrillation and chronic renal failure are common diseases in the population with similar risk factors. Both conditions are independent riskfactors for the development of thromboembolic complications. There is compelling evidence to support the benefits of anticoagulant therapy for atrial fibrillation in the general population, but in patients with advanced chronic renal failure, the use of anticoagulants may be limited. A number of studies have shown conflicting results, and this topic is of interest for further discussion and a comprehensive analysis of the existing data.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
